Summary
4′, 6-Dichloroflavan, a potent inhibitor of rhinovirus replicationin vitro, was tested in a double-blind placebo controlled volunteer trial for its protective effect against experimental rhinovirus infection. Dichloroflavan was given orally (1 mg/kg, 3 times per day) for 3 doses before, and 13 doses after intransasal challenge with rhinovirus type 9, a type known to be highly sensitive in tissue culture. A total of 63 volunteers were included in the analysis for efficacy.
Dichloroflavan did not produce any consistent or significant reduction in quantitative clinical or laboratory evidence of infection, and there was no apparent negative correlation of such data with drug concentrations in plasma. It is concluded that administration of dichloroflavan in the oral formulation tested is not of value in the treatment of human rhinovirus infection.
Article PDF
Similar content being viewed by others
References
Bauer, D. J., Selway, J. W. T., Batchelor, J. F., Tisdale, M., Caldwell, I. C., Young, D. A. B.: 4′, 6, Dichloroflavan (BW 683) a new anti-rhinovirus compound. Nature292, 369–370 (1981).
Beare, A. S., Reed, S. E.: The study of antiviral compounds in volunteers. In:Oxford, J. (ed.), Chemoprophylaxis and viral infections of the respiratory tract, 27–55. Cleveland: CRC Press 1977.
Fowler, A. S. E., Freestone, D. S.: Personal Communication.
Horn, M. E. C., Reed, S. E., Taylor, P.: Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch. Dis. Childhood54, 587–592 (1979).
Larson, H. E., Reed, S. E., Tyrrell, D. A. J.: Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol.5, 221–229 (1980).
McHardy, V., Inglis, J. M., Calder, A., Crofton, J. W., Grigg, I., Ryland, D. A., Taylor, P., Chadwick, M., Coombs, B., Riddell, R. W.: A study of infective and other factors in exacerbations of chronic bronchitis. Brit. J. Dis. Chest.74, 228–238 (1980).
Meddis, R.: Unified analysis of variance by ranks. Brit. J. Math. and Statist. Psych.33, 84–98 (1980).
Phillpotts, R. J., Jones, R. W., DeLong, D. C., Reed, S. E., Wallace, J., Tyrrell, D. A. J.: The activity of enviroxime against rhinovirus infection in man. Lancetii, 1342–1344 (1981).
Reed, S. E., Craig, J. W., Tyrrell, D. A. J.: Four compounds active against rhinovirus: Comparisonin vitro and in volunteers. J. Infect. Dis.133, A128-A135 (Suppl.) (1976).
Reed, S. E.: The assessment of antirhinoviral compounds with clinical potential. In:Collier, L. H., Oxford, J. (eds.), Developments in antiviral therapy. London: Academic Press 1980.
Snedecor, G. W., Cochran, W. G.: In: Statistical methods, 111–113. Publ. Iowa State University 1976.
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Phillpotts, R.J., Wallace, J., Tyrrell, D.A.J. et al. Failure of oral 4′, 6-dichloroflavan to protect against rhinovirus infection in man. Archives of Virology 75, 115–121 (1983). https://doi.org/10.1007/BF01314131
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314131